VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 703 filers reported holding VANECK VECTORS ETF TR in Q3 2023. The put-call ratio across all filers is 0.70 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $9,553 | -3.9% | 355,000 | +7.5% | 0.12% | +33.7% |
| Q2 2023 | $9,940 | +375.1% | 330,124 | +410.5% | 0.09% | +411.1% |
| Q1 2023 | $2,092 | -99.9% | 64,673 | -15.5% | 0.02% | +5.9% |
| Q1 2022 | $2,936,000 | +25.6% | 76,568 | +4.9% | 0.02% | +54.5% |
| Q4 2021 | $2,338,000 | -35.9% | 73,001 | -42.1% | 0.01% | -50.0% |
| Q3 2021 | $3,646,000 | +445.0% | 126,101 | +578.7% | 0.02% | +266.7% |
| Q4 2020 | $669,000 | -90.9% | 18,580 | -90.7% | 0.01% | -91.5% |
| Q3 2020 | $7,333,000 | 0.0% | 199,911 | 0.0% | 0.07% | -34.3% |
| Q2 2020 | $7,333,000 | +84.0% | 199,911 | +14.4% | 0.11% | -71.6% |
| Q1 2017 | $3,985,000 | – | 174,687 | – | 0.38% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 738,500 | $19,873,035 | 80.92% |
| New Harbor Financial Group, LLC | 1,680,752 | $45,229,033 | 14.96% |
| TORQ CAPITAL MANAGEMENT (HK) Ltd | 139,000 | $3,740,490 | 9.95% |
| Vanderbilt University | 1,360,540 | $36,612,131 | 9.45% |
| Eschler Asset Management LLP | 300,000 | $8,073,000 | 9.42% |
| New Harbor Financial Group, LLC | 1,027,300 | $27,644,643 | 9.15% |
| Guild Investment Management, Inc. | 139,333 | $3,749,454 | 6.28% |
| Monaco Asset Management SAM | 750,000 | $20,182,500 | 5.98% |
| STRATEGIC INVESTMENT MANAGEMENT, LLC | 132,460 | $3,867,832 | 4.74% |
| PCG Wealth Advisors, LLC | 264,614 | $7,120,782 | 4.67% |